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Background: Self-management strategies have the potential to support patients with chronic obstructive pulmonary
disease (COPD). Telehealth interventions may have a role in delivering this support along with the opportunity to
monitor symptoms and physiological variables. This paper reports findings from a six-month, clinical, cohort study of
COPD patients’ use of a mobile telehealth based (mHealth) application and how individually determined alerts in
oxygen saturation levels, pulse rate and symptoms scores related to patient self-initiated treatment for exacerbations.
Methods: The development of the mHealth intervention involved a patient focus group and multidisciplinary team of
researchers, engineers and clinicians. Individual data thresholds to set alerts were determined, and the relationship to
exacerbations, defined by the initiation of stand-by medications, was measured. The sample comprised 18 patients
(age range of 50–85 years) with varied levels of computer skills.
Results: Patients identified no difficulties in using the mHealth application and used all functions available. 40 % of
exacerbations had an alert signal during the three days prior to a patient starting medication. Patients were able to use
the mHealth application to support self- management, including monitoring of clinical data. Within three months, 95 %
of symptom reporting sessions were completed in less than 100 s.
Conclusions: Home based, unassisted, daily use of the mHealth platform is feasible and acceptable to people with
COPD for reporting daily symptoms and medicine use, and to measure physiological variables such as pulse rate and
oxygen saturation. These findings provide evidence for integrating telehealth interventions with clinical care pathways
to support self-management in COPD.
Keywords: Chronic obstructive pulmonary disease, Chronic condition, Self-management, Telehealth, Digital health,
E-health, Mobile health, AlertsBackground
Chronic obstructive pulmonary disease (COPD) is a com-
mon condition worldwide which has a significant impact
on all domains of patients’ health related quality of life
[1, 2]. In addition, one in eight UK acute emergency ad-
missions is the result of an acute COPD exacerbation,
and 90 day re-admission rates are as high as 30 % [3].* Correspondence: carmelo.velardo@eng.ox.ac.uk
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creativecommons.org/publicdomain/zero/1.0/Self-management strategies have the potential to im-
prove quality of life and reduce hospital admissions [4].
However results of existing studies employing a variety
of self-management strategies are mixed [5, 6] and it re-
mains unclear which forms of self-management are suit-
able for individual patients, or how they are best placed
in patient pathways and supported by community re-
spiratory nurses in conjunction with primary care teams.
Therefore innovative approaches to self-management are
required, which maintain a patient-centred approach.article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
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help patients self-manage their condition by delivering
individually tailored education and treatment plans, and
by providing support to patients to monitor and inter-
pret their own physiological data. In addition, these in-
terventions can reduce patients’ sense of isolation and
improve self-efficacy [7]. Telehealth also has the potential
to allow health care professionals to monitor remotely for
deteriorations or long-term trends, and offers opportun-
ities for intervention to improve outcomes. Systematic re-
views of the use of telehealth in COPD have focused on
telemonitoring with remote decision-making by health
care professionals and have not shown convincing evi-
dence of effectiveness on hospital admissions [8]. Despite
the lack of evidence there are many telehealth projects
currently underway in a variety of NHS organisations
which remain poorly validated.
The specifications for a telehealth solution that could be
implemented in NHS practice, and are likely to be feasible
and acceptable to both patients and health care profes-
sionals would include low cost, ease-of-use, based on a
generic technology and integrated within care pathways.
In addition, it would need to be capable of deployment on
a large scale and of delivering improved self-management.
The sElf-management anD support proGrammE (EDGE)
project [9], was set up to develop and test the efficacy
of an internet-linked tablet computer based mobile health
(mHealth) system, designed according to these specifica-
tions, in improving quality of life in patients with moder-
ate to severe COPD. The mHealth system was developed
for use by people with varying computer skills, with the
aim of ensuring data quality and integration of the system
within clinical care to deliver self-management support.
We set out to evaluate the use of the system in a cohort
study during which directly-measured clinical variables
and patient-reported variables were measured throughout
a six-month period.
Methods
Development of mHealth system
The mHealth system used in this study consisted of an
internet-linked Android tablet computing device running
a software application, which was intended for use by
people with varying computer skills. A multi-disciplinary
team was involved in the design of the system and the im-
plementation of the project: this included primary care
physicians, respiratory nurses, a secondary care respiratory
physician, a psychiatrist, and engineers. A small group of
patients, who were not involved in the cohort study, acted
as a participant informant group and provided guidance
and feedback for development of the software application.
The involvement of a patient focus group enabled the soft-
ware to be optimised so that patients could record data
with ease and access educational materials (an example ofuser interface can be seen in the Appendix). Evidence-
based self-management strategies were included in the
education materials which were based on the principles of
pulmonary rehabilitation. Technical development focused
on enabling the acquisition of high-quality data, with
artefactual data filtered out, and on making the data
visible in real time to both patient users and healthcare
professionals. The resulting mHealth system was integrated
within existing local clinical care pathways following
discussion with patients about how they might use data,
and with relevant healthcare professionals about how they
would monitor data and interact with patients (an over-
view of the system and interactions with patients and
health professionals is available in the Appendix).
The self-management module of the mHealth system
included the facility for patients to keep a daily symptom
diary which included questions about their general well-
being, cough and sputum production (quantity and colour),
and breathlessness to allow exacerbation detection based
on questions used in previous trials [10, 11]. An option to
record medication use was included with diary-based ques-
tions on use of inhalers, antibiotics and oral steroids (or a
combination of these medicines). An exacerbation ‘event’
was deemed to have occurred when patients initiated the
use of either antibiotics, oral steroids or both antibiotics
and steroids. Pulse rate and oxygen saturation, computed
from a 30-s period of data acquired with a pulse oximeter
(Nonin Onyx II 9650) and its finger probe, were collected
daily and transmitted wirelessly to the tablet (Samsung
Galaxy Tab 2) via Bluetooth. Additional self-management
support was provided via software modules: (i) persona-
lised plans for self-management developed from a stand-
ard care plan and for treating an exacerbation; (ii) 14 brief
video clips and text-based material (see Table 1) providing
disease education, advice on managing COPD including
diet, medicine use and inhaler technique (patients could
only view the inhalers they had been prescribed); (iii) the
facility to receive a brief message from the trial respiratory
nurse. In addition, personalised self-management plans
could be modified or updated remotely according to pa-
tients’ needs. The videos were scripted by a respiratory re-
search nurse, reviewed by the respiratory consultant and
filmed by the research team. In addition, personalised self-
management plans and inhalers videos could be modified
or updated remotely as patients required.
The patient-acquired data, after completion of the diary
on the tablet computer, were automatically synchronised
with a remote, secure server (within the NHS network
and behind the NHS firewall). Data collected were ana-
lysed using patient-specific probabilistic models. For each
patient, an initial 6-week (training) period was used to
generate personalised alert thresholds for symptom score,
oxygen saturation, and pulse rate. Using these thresholds,
we tested all data points outside the training period and
Table 1 Video clips to support self-management and frequency
of viewing
Video ID Video Title
Inhaler technique videos 1 How to use the Handihaler
2 How to use the Accuhaler
3 How to use the Metered Dose
Inhaler
4 How to use the Turbohaler
7 How to use the Aerochamber
11 How to use the Respimat






9 Manage my breathing
13 My breathing exercises
Mood management 8 Manage my mood
10 Manage my worry
12 Relaxation technique
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below in case of oxygen saturation) the threshold value.
Research ethics committee
Ethical approval was obtained from South Central Berk-
shire Research Ethics Committee (ref 12/SC/0437) and
Research Governance was granted by Oxford Health
NHS Foundation Trust and Oxford University Hospitals
NHS Trust.
Patient recruitment
For the six-month cohort study, patients meeting the in-
clusion criteria were identified and recruited from a var-
iety of healthcare settings: hospital admission records,
respiratory out-patient clinics, pulmonary rehabilitation
programmes. Patients with COPD were also recruited
through disease registers held by primary care based
physicians (general practitioners) providing community
based management. Inclusion criteria included aged over
40 years, a smoking pack year history of greater than 10
pack years, MRC dyspnoea scale greater than or equal to
2, post bronchodilator forced expiratory volume in one
second (FEV1) of less than 80 % and an FEV1/forced
vital capacity ratio of less than 70 % (which were mea-
sured pre and post study by a trained respiratory re-
search nurse), exacerbation of COPD requiring treatment
or referred to pulmonary rehabilitation within last year,
absence of other significant lung disease or heart failure,
life expectancy of greater than three months and ability to
understand written English. Within one week of recruit-
ment to the pilot cohort study the respiratory research
nurse delivered the tablet computer during a home visit,during which full written consent was taken and the pa-
tient was instructed in the use of the tablet computer, in-
cluding how to complete the symptom diary, access
educational materials and use the oximetry probe. Each
patient was provided with an instruction leaflet designed
by the research team, and a contact number for the re-
spiratory research nurse if they encountered any prob-
lems. Patients were asked to complete diaries and
measure their oxygen saturation levels and pulse rate on a
daily basis at a time of their choosing. They were informed
that the data they sent would be looked at on a weekly
basis to review trends: however, if they felt unwell they
were to contact their usual health care professional for ad-
vice. The respiratory research nurse would contact the pa-
tients by phone in the case of a period of missing data
(>7 days) or if the patient entered the alert zone for two
consecutive days.
Data collection
The time taken for the first home visit by the respiratory
nurse, during which instruction on how to use the mHealth
tablet was given, was recorded. Patient-reported data for
symptoms and the pulse oximetry data (oxygen saturation
and pulse rate) were downloaded from the study server
behind the NHS firewall onto an Excel spreadsheet.
The number of times patients completed self-management
diaries, accessed self-management plans, educational vid-
eos and respiratory nurse messaging was also downloaded
onto the Excel spreadsheet. The times taken for patients to
complete their daily symptom and medication diary and
their pulse rate/oxygen saturation measurements using
pulse oximetry were measured. Data were reported using
descriptive statistics.
Data analysis
Data collected on the secure server were analysed using
patient-specific probabilistic models in order to compute
an alert threshold for each data type (symptom score,
oxygen saturation and pulse rate), for each patient. The
statistics for each patient and for each data type were
determined during a run-in period (6-week or 40 sets
of diaries completed), from which the probability dens-
ity functions (PDF) were estimated for each data type,
providing an individualised probability of encountering
a specific value for that data type, for that patient. From
this information, a cumulative density function was com-
puted and used to set a patient-specific alert threshold
(95 % centile), as illustrated in Fig. 1. The data were
displayed to the respiratory research nurse using time
plots that showed when a patient-specific threshold was
exceeded (“alert condition”). However these alerts were
not visible to the patients in the cohort study.
To analyse usage patterns, user interactions with the
tablet were recorded and data analytics about the use of
Fig. 1 Computation of an alert threshold. Symptom score as recorded in patient’s computer tablet (top trace), histogram depicting data
distribution (lower left plot), probability density function PDF (lower middle plot), cumulative density function CDF (lower right plot), with patient-
specific alert threshold value derived from 95th centile of CDF
Table 2 Patient demographics
Number (%)
Age 40-50 year 6 %
51-60 year 6 %
61-70 year 33 %
71-80 year 44 %
81-90 year 11 %
Gender (M;F) Male 9 (50 %), Female 9 (50 %)







Not recorded at entry
to study
1 (6 %)
Computer skills 83 % had a computer, of whom
13 % Never used their computer
13 % Hardly ever used their computer
20 % Sometimes used their computer
7 % Quite frequently used their computer
47 % Used their computer every day
MRC dyspnoea scale MRC 2 - 0 %,
MRC 3 - 89 %
MRC - 4 11 %
Hospital admissions
during study
9 hospital admission in total, 7 COPD related,
1 cardiac related and 1 lung surgery
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mote server. Using this information we computed the
time taken to use each separate section of the applica-
tion, the symptom diary, and the videos. In order to esti-
mate the monthly trend of the time taken to complete
the symptom diary and oxygen saturation measurement,
a cumulative distribution function was computed from
daily data for all patients in each month of the study.
Results
Use of mHealth system
Twenty-three patients were given the mHealth system to
use for a 6-month period, with 18 of these completing
the full six-month study. One patient died and four
others did not complete the study: there were technical
problems affecting one patient’s use of the tablet on day
13 which, although resolved, led to the patient deciding
to withdraw; two patients had multiple hospital admis-
sions and became too unwell and one patient disliked
the system describing it as ‘too slow’. Patients were re-
cruited following hospital admission for an exacerbation
of COPD, and from respiratory out-patient clinics, pul-
monary rehabilitation programmes and GP practices
Table 2. Gives details of participant characteristics, they
had moderate to severe COPD as defined by MRC dys-
pnoea score and Gold Classification and were of a wide
age range. Participants were prescribed a range of COPD
related medication, with the majority of patients using
inhaled salbutamol, salmeterol and tiotropium. Partici-
pants had a range of pre-existing computer skills from
not having a computer to using it regularly. The initial
Table 3 Symptom scores, pulse rate, and Oxygen saturation
statistics for run-in and follow-up period
Trait Run-in mean (std) Follow-up mean (std)
Symptom scores 9.6 (2.4) 9.1 (2.7)
Pulse rate 83.4 (17.1) 83.5 (16.9)
Oxygen Saturation 93.8 (3.0) 93.2 (3.6)
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time to instruct on tablet use, which took between 10
and 20 min, depending on prior patient experience of
using similar technology. Three months after commen-
cing the study, 95 % of diaries and oxygen saturation
measurements were completed within 100 s. Moreover,
patient did not reported any difficulty with entering their
data on the EDGE mobile application [14].
Patients completed the symptom score and medication
use diary, and recorded their oxygen saturation and pulse
rate for an average of 77 % of trial days (range 40-98 %),
Table 3 presents a summary of the diary scores and vital
signs recorded during the cohort study. 78 % of partici-
pants completed their diaries and measured their oxygen
saturation and pulse rate on at least 5 days/week through-
out the six months. Self-management plans were accessed
by all patients (mean 9.8 times, range 3–40). 16 of 18 pa-
tients accessed the self-management videos (mean 3.9
times, range 0–11). All 14 individual video clips wereFig. 2 Number of times videos watched. Number of times each video wasaccessed (mean 8.5 times, range 1–19), the most popular
video being “How to use an MDI inhaler”. Video clips
about inhaler technique, exercise and pulmonary re-
habilitation and mood management were watched a simi-
lar number of times (means of 8.1, 9.8 and 7.6 times
respectively). 17 patients accessed messages from the
respiratory research nurse (mean 29.7 times, range 0–169)
(Fig. 2).
Alerts and their relationship to events
There were a total of 189 alerts generated: 47 symptom
diary alerts were received from 16 participants (mean 2.9,
SD1.6), 80 pulse rate alerts were received from 18 partici-
pants (mean 4.4, SD2.5) and 62 oxygen saturation alerts
were received from 17 participants, (mean 3.6 SD2.6). 37
‘exacerbation’ events were identified in 16 participants
(mean 2.3, SD 1.5). Of the 37 events, 15 (40.5 %) were pre-
ceded by one or more alert in the 3 days prior to the
event. Events associated with alerts were identified in 11
(61 %) of the participants. In total, 4 false positives (event
flagged that did not correspond to a medication event)
and 4 false negatives (medication events that were not an-
ticipated by any alert) were identified.
Discussion
We have shown that regardless of previous computer
experience and age, a well-designed mHealth system canwatched during the cohort study
Fig. 3 UML interaction diagram
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taught how to use the tablet in a short dedicated visit,
and within an acceptable time frame of three months
were entering data regularly at a time of their
choosing. Compliance with the mHealth system was
high, with the majority of patients using the pulse
oximeter to measure their oxygen saturation and pulse
rate, and record their symptoms and medicine use
on a regular basis. Most accessed the range of self-
management support modules available including their
self-management plan and the range of video clips, es-
pecially those focusing on inhaler technique. Patients
also accessed messages from the respiratory research
nurse demonstrating the acceptability of this form of
communication with a healthcare professional.
The estimation of individualised alert thresholds was
feasible, and a proportion of alerts occurred during thethree days preceding ‘events’, when patients decided to
initiate their standby medicines to treat an exacerbation.
This was a small preliminary study focussing on the
usability of the mHealth system and the self-management
support modules it included. Patients appeared to like
having access to video content to support inhaler tech-
nique. This represents a potentially new way of teaching
good inhaler technique, which is vital to achieving the
clinical benefits of appropriate inhaler use. Videos were
accessed in all subject areas and often on multiple oc-
casions demonstrating the flexibility of the system for
users. This multi-media format, which can also be used
to deliver exercise advice from pulmonary rehabilitation
programmes, provides a means of reinforcing self-
management strategies. It is possible that patient inter-
est in videos would wane over time, however, and this
study was too short to evaluate this.
Fig. 4 Mobile application user interface
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intervention included a substantial element of support
for self-management. Patients could enter data at a
time of their choosing (although the analysis of the
application usage showed that patients consistently
used the application at about the same time, ± 1 h),
and there was an opportunity for them to monitor
their data and to observe trends over time. Patients
did not voice any concerns that their data was
reviewed only on a weekly basis, with a respiratory re-
search nurse using the messaging facility as appropri-
ate, and continued to interact with their usual
healthcare professionals as required. Existing tele-
health systems have often restricted times of data
entry rather than fitted with individual patientlifestyles, with frequent data errors requiring repeated
data entry. They have also tended to rely on remote
monitoring by clinicians rather than on empowering
patients to make their own health care decisions
[12, 13, 16]. Fixed alerting thresholds are based on the
average experience of a cohort [15, 16]. However, pa-
tients can be stable, whilst providing physiological
measurements that might permanently lead to alerts
(e.g. 92 % is often used as a threshold for alerting on
Oxygen saturation, yet some patients are stable at
lower levels, and some patients might repeatedly re-
port certain symptoms thus increasing their scores). By
producing a user-friendly mHealth system that is capable
of flexible integration into existing care pathways, there is
now an opportunity for optimising existing care pathways
Fig. 5 Daily symptom questionnaire
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fashion. This approach needs to be further evaluated and
compared with standard care. The results of this cohort
study, along with the results from a qualitative study con-
ducted in parallel with this patient group [14] have been
used to inform the design of a randomised controlled trial
currently underway.
Limitations
We used a novel methodology to derive individualised
alerting thresholds, and then reviewed medicine use data
in the three preceding days to identify any ‘events’ for
which patients took their standby medicines to treat an
exacerbation. Other than identifying the fact that 40 %
of the alerts were related to events, the study was too
small to draw firm conclusions about the association be-
tween alerts and events, which is likely to be complex
and influenced by past patient experience and healthcare
beliefs.
The findings of this study need to be validated in a
randomised control trial: this is now taking place and re-
cruitment to the 12-month follow-up clinical trial is now
complete. The outcomes of this trial will determine whether
there are improvements in quality of life with the use
of the software application and an associated reduction
in use of healthcare resources (primary care clinic at-
tendances and hospital admissions).
The EDGE application was used with a pulse oximeter,
in case of co-morbidities the number of external devices
used in combination with the application might increase.
It is worth noticing that the number of external device
might increase the burden to the user, and eventually gen-
erate lower compliance rates. For this reason the authors
consider very important to experiment the set-up of such
interventions with cohort studies like the one described in
this article.
Conclusions
The findings of this cohort study confirm that daily use
of the mHealth platform is feasible and acceptable to
people with COPD for reporting daily symptoms and medi-
cine use, and to measure physiological variables such
as pulse rate and oxygen saturation. Features to support
self-management such as video clips, self-management
plans and respiratory nursing messaging were accessed
by the majority of patients. The development of indivi-
dualised alert thresholds has the potential to identify
exacerbations early but requires further evaluation.
Endnotes
1We assessed patient acceptance using qualitative
methods, the results of which have been published in a
separate paper [14].Appendix
Schema of interactions
Figure 3 displays the interactions between the actors
(patients and health specialists) and the EDGE m-Health
system.
m-Health application
Figure 4 shows the application user interface. The design
strategy focussed on usability and readability of the content.
A co-design workshop was employed to collect feedback
from a group of patients.
Questionnaires
Here we report the set of questions used in the cohort
study. The flowchart shows the flow of questions de-
signed such that the patients will be asked only pertinent
questions (Fig. 5).
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